Detalhe da pesquisa
1.
TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
J Immunol
; 185(12): 7731-8, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21068401
2.
Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.
Immunology
; 130(2): 288-95, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20102408
3.
Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.
ACS Chem Biol
; 9(1): 247-57, 2014 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24117378
4.
TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.
PLoS One
; 5(8): e12087, 2010 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20711470
5.
Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease.
J Immunol
; 180(11): 7764-73, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18490781
6.
Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance.
Clin Immunol
; 123(3): 252-7, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17449325
7.
Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection.
Clin Immunol
; 122(3): 271-8, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17157070